Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding protein MEX3A is a member of the MEX-3 family of evolutionarily conserved RNA-binding proteins defined by two KH (K homology) domains and a carboxy-terminal RING finger domain. MEX3A acts as a post-transcriptional regulator, binding to 3' untranslated regions of target mRNAs, promoting mRNA decay, and influencing translation efficiency. It can shuttle between the nucleus and cytoplasm, localizing in P-bodies—sites of mRNA turnover. In mammals, MEX3A is implicated in critical cellular processes such as stem cell self-renewal, the maintenance of undifferentiated cell states, and the regulation of proliferation and cell cycle progression. Overexpression of MEX3A has been consistently linked to heightened tumorigenicity and poor prognosis in several cancers, making it of interest as a therapeutic target and biomarker for patient selection[1][2][5][8].
Inhibitors targeting MEX3A would likely act by blocking its RNA binding activity or disrupting its E3 ubiquitin ligase function, thereby stabilizing target tumor-suppressive mRNAs and attenuating proliferative signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding protein MEX3A (MEX3A).